CE: Original Research: Antineoplastic Drug Administration by Pregnant and Nonpregnant Nurses: An Exploration of the Use of Protective Gloves and Gowns
Autor: | Thomas H. Connor, Carissa M. Rocheleau, Christina C. Lawson, Feiby L. Nassan, Jorge E. Chavarro, Candice Y. Johnson, Janet W. Rich-Edwards, James M. Boiano |
---|---|
Rok vydání: | 2019 |
Předmět: |
medicine.medical_specialty
Education Continuing MEDLINE Antineoplastic Agents 03 medical and health sciences Protective Clothing Pregnancy Protective gloves Occupational Exposure Health care medicine Humans Intensive care medicine General Nursing 030504 nursing business.industry Case-control study Cancer General Medicine medicine.disease Case-Control Studies Female Occupational exposure Gloves Protective 0305 other medical science business Pregnancy Complications Neoplastic Administration (government) |
Zdroj: | AJN, American Journal of Nursing. 119:28-35 |
ISSN: | 0002-936X |
DOI: | 10.1097/01.naj.0000552583.69729.51 |
Popis: | Background: Many antineoplastic (chemotherapeutic) drugs are known or probable human carcinogens, and many have been shown to be reproductive toxicants in cancer patients. Evidence from occupational exposure studies suggests that health care workers who have long-term, low-level occupational exposure to antineoplastic drugs have an increased risk of adverse reproductive outcomes. It's recommended that, at minimum, nurses who handle or administer such drugs should wear double gloves and a nonabsorbent gown to protect themselves. But it's unclear to what extent nurses do.This study assessed glove and gown use by female pregnant and nonpregnant nurses who administer antineoplastic drugs in the United States and Canada.We used data collected from more than 40,000 nurses participating in the Nurses' Health Study 3. The use of gloves and gowns and administration of antineoplastic drugs within the past month (among nonpregnant nurses) or within the first 20 weeks of pregnancy (among pregnant nurses) were self-reported via questionnaire.Administration of antineoplastic drugs at any time during their career was reported by 36% of nonpregnant nurses, including 27% who reported administering these drugs within the past month. Seven percent of pregnant nurses reported administering antineoplastic drugs during the first 20 weeks of pregnancy. Twelve percent of nonpregnant nurses and 9% of pregnant nurses indicated that they never wore gloves when administering antineoplastic drugs, and 42% of nonpregnant nurses and 38% of pregnant nurses reported never using a gown. The percentage of nonpregnant nurses who reported not wearing gloves varied by type of administration: 32% of those who administered antineoplastic drugs only as crushed pills never wore gloves, compared with 5% of those who administered such drugs only via infusion.Despite longstanding recommendations for the safe handling of antineoplastic and other hazardous drugs, many nurses-including those who are pregnant-reported not wearing protective gloves and gowns, which are considered the minimum protective equipment when administering such drugs. These findings underscore the need for further education and training to ensure that both employers and nurses understand the risks involved and know which precautionary measures will minimize such exposures. |
Databáze: | OpenAIRE |
Externí odkaz: |